Advance Search
HAN Qinglin, LU Wenjuan, LI Shudi. Therapeutic effect of Shuli Shaoyang Prescription for refractory depression[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 63-67. DOI: 10.7619/jcmp.20210735
Citation: HAN Qinglin, LU Wenjuan, LI Shudi. Therapeutic effect of Shuli Shaoyang Prescription for refractory depression[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 63-67. DOI: 10.7619/jcmp.20210735
shu

Therapeutic effect of Shuli Shaoyang Prescription for refractory depression

  • Department of Psychology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei, 061001

More Information
  • Received Date: February 22, 2021
  • Available Online: June 14, 2021
  • Published Date: June 14, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the therapeutic effect of Shuli Shaoyang Prescription on refractory depression and its effects on brain-derived neurotrophic factor(BDNF) and neurotransmitter levels.
      Methods  Eighty patients with refractory depression admitted to the psychological outpatient department of our hospital were selected as research objects, and were randomly divided into observation group and control group, with 40 cases in each group. The control group was given paroxetine hydrochloride tablets for oral administration, while the observation group added with Shuli Shaoyang Prescription based on the control group. After continuous treatment for 8 weeks, the efficacy and adverse reactions of the two groups were observed and compared. The scores of TCM syndrome, 17-Item Hamilton Rating Scale for Depression(HAMD-17), Hamilton Anxiety Scale (HAMA), Symptom Checklist 90 (SCL-90), and the changes in the levels of BDNF and neurotransmitter were compared between the two groups before and after treatment.
      Results  After treatment, the scores of TCM syndrome, HAMD-17, HAMA and SCL-90 of patients in both groups were significantly reduced, and the observation group was significantly lower than those of the control group (P < 0.05). The clinical total effective rate of the observation group was significantly higher than that of the control group (P < 0.05). After treatment, the levels of 5-hydroxytryptamine (5-HT), norepinephrine (NE), neuropeptide Y (NPY) and mature BDNF (mBDNF) and tyrosine kinase receptor B of BDNF (TrkB) in the two groups were significantly increased after treatment, and the above indicators in the observation group were significantly higher than those of the control group (P < 0.05), while the substance P (SP) and precursor of BDNF (proBDNF) levels were significantly decreased, and they were significantly lower in the observation group than those in the control group (P < 0.05). The adverse reactions in the observation group was 15.00%, which was lower than 20.00% in the control group, but there was no statistically significant difference between the two groups (P>0.05).
      Conclusion  Shuli Shaoyang Prescription can significantly enhance curative effect in treatment of refractory depression, improve the patients' emotions such as depression, anxiety. Therefore, emotions may be regulated by regulating the levels of BDNF and neurotransmitters.
    • FullText(HTML)
    • References (24)
  • [1]
    姜默琳, 尤圣杰, 张捷. 近5年中药复方抗抑郁机制研究进展[J]. 中华中医药杂志, 2018, 33(10): 4571-4574. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201810084.htm
    [2]
    PANDARAKALAM J P. Challenges of treatment-resistant depression[J]. Psychiatr Danub, 2018, 30(3): 273-284. http://www.ncbi.nlm.nih.gov/pubmed/30267518
    [3]
    刘欢乐, 卫拂晓, 秦雪梅, 等. 中西药联合用药抗抑郁研究进展[J]. 中国中药杂志, 2020, 45(16): 3776-3783. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202016004.htm
    [4]
    陈宁贵, 廖敏. 解郁丸联合西酞普兰治疗难治性抑郁症的疗效及其对血清去甲肾上腺素和5-羟色胺及脑源性神经营养因子指标的影响研究[J]. 中国全科医学, 2017(S2): 338-340. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX2017S2131.htm
    [5]
    岳秀宁, 刘正福, 叶兰仙, 等. 难治性抑郁症的治疗进展[J]. 2016, 25(3): 280-284. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMYX201713024.htm
    [6]
    张磊阳, 蒋健, 贺敏, 等. 抗抑郁中药的药理研究进展[J]. 中国实验方剂学杂志, 2017, 23(24): 224-234. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201724037.htm
    [7]
    中华医学会精神病学分会. 中国精神障碍分类与诊断标准第三版(精神障碍分类)[J]. 中华精神科杂志, 2001, 34(3): 184-188. doi: 10.3760/j:issn:1006-7884.2001.03.028
    [8]
    国家中医药管理局. 中医病证诊断疗效标准[M]. 北京: 中国医药科技出版社, 2012: 109-111.
    [9]
    国家中医药管理局. 中药新药临床研究指导原则(试行)[S]. 北京: 中国医药科技出版社, 2002: 240-243.
    [10]
    吴捷, 余阳, 林齐鸣. 抑郁症五脏病机研究进展[J]. 辽宁中医药大学学报, 2012, 14(2): 197-199. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201202089.htm
    [11]
    朱智羽, 郭闫葵. 中医辨证下的抑郁症病因病机及治疗概述[J]. 中医药临床杂志, 2019, 31(4): 788-791. https://www.cnki.com.cn/Article/CJFDTOTAL-AHLC201904058.htm
    [12]
    宋清雅, 孙龙吉, 崔人匀, 等. 从肾虚论治郁证[J]. 河南中医, 2019, 39(4): 499-504. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZY201904004.htm
    [13]
    王省, 陈刚. 试论枢转少阳与快速抗抑郁[J]. 中医杂志, 2017, 58(2): 173-175. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201702021.htm
    [14]
    余云进, 谢宇锋, 冯军, 等. 基于"少阳为枢"理论浅析针刺治疗青少年抑郁[J]. 中国针灸, 2019, 39(12): 1353-1356. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE201912032.htm
    [15]
    芦文娟, 韩庆林, 李书迪. 疏利少阳法治疗抑郁症理论探讨[J]. 山东中医药大学学报, 2017, 41(4): 307-309, 316. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYX201704004.htm
    [16]
    KOWIAÑSKI P, LIETZAU G, CZUBA E, et al. BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity[J]. Cell Mol Neurobiol, 2018, 38(3): 579-593. doi: 10.1007/s10571-017-0510-4
    [17]
    LEAL G, COMPRIDO D, DUARTE C B. BDNF-induced local protein synthesis and synaptic plasticity[J]. Neuropharmacology, 2014, 76(Pt C): 639-656. http://www.sciencedirect.com/science/article/pii/S0028390813001421
    [18]
    王思琪, 苏静, 马世平, 等. 脑源性神经营养因子在抑郁症中的研究进展[J]. 药学与临床研究, 2020, 28(4): 279-282. https://www.cnki.com.cn/Article/CJFDTOTAL-YXLY202004010.htm
    [19]
    NICULESCU D, MICHAELSEN-PREUSSE K, GVNER V, et al. A BDNF-mediated push-pull plasticity mechanism for synaptic clustering[J]. Cell Rep, 2018, 24(8): 2063-2074. doi: 10.1016/j.celrep.2018.07.073
    [20]
    ZHOU L, XIONG J, LIM Y, et al. Upregulation of blood proBDNF and its receptors in major depression[J]. J Affect Disord, 2013, 150(3): 776-784. doi: 10.1016/j.jad.2013.03.002
    [21]
    JIANG H, CHEN S, LI C, et al. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment[J]. Transl Psychiatry, 2017, 7(4): e1079. doi: 10.1038/tp.2017.43
    [22]
    BEREZHNOY D S, FEDOROVA T N, STVOLINSKII S L, et al. Carnosine modulates oxidative homeostasis and levels of neurotransmitters in the brain in models of learning with positive and negative reinforcement[J]. Neurochem J, 2016, 10(4): 273-279. doi: 10.1134/S1819712416040048
    [23]
    JARACZ J, GATTNER K, JARACZ K, et al. Unexplained painful physical symptoms in patients with major depressive disorder: prevalence, pathophysiology and management[J]. CNS Drugs, 2016, 30(4): 293-304. doi: 10.1007/s40263-016-0328-5
    [24]
    汪莲籽, 候正华, 吴明飞, 等. 单相抑郁症与双相障碍抑郁相患者神经肽Y、P物质水平差异及其与抑郁严重程度的相关性分析[J]. 国际精神病学杂志, 2017, 44(4): 582-284, 601. https://www.cnki.com.cn/Article/CJFDTOTAL-GWYJ201704001.htm
    • Related Articles

  • Related Articles

    [1]SONG Huahua, ZHU Ronghua, SHI Li. Correlations of serum levels of brain-derived neurotrophic factor, malondialdehyde, endothelin-1 and heat shock protein 70 with cognitive dysfunction in patients with obstructive sleep apnea hypopnea syndrome[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 70-74. DOI: 10.7619/jcmp.20242760
    [2]SUN Qin, ZHANG Wen, XU Mengyuan, XU Suqing, ZHAO Haihe, JIN Minli. Effect of four traditional Chinese drugs for reinforcing kidney combined with Tongqiao Huoxue Decoction on serum neurotransmitters and neurological function in patients with post-stroke cognitive impairment[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 89-93. DOI: 10.7619/jcmp.20242642
    [3]SUN Yan, WANG Xia, HE Fengying, NIU Meiyan, YU Ruiping, ZHANG Airong. Effects of dietary behavior intervention on expressions of serum α-synuclein, brain-derived neurotrophic factor and glutamate in children with autism spectrum disorders[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 80-84. DOI: 10.7619/jcmp.20221894
    [4]ZHONG Yunian, ZHAO Yilin, XIAO Wenhuan, YANG Xiang, XU Ying. Relationships of cognitive function with inflammatory factors and glial cell line-derived neurotrophic factor in patients with bipolar disorders[J]. Journal of Clinical Medicine in Practice, 2022, 26(6): 58-62. DOI: 10.7619/jcmp.20213016
    [5]WANG Jing, ZHAO Yilin, XIAO Wenhuan, WU Hui. Comparison in hematological inflammatory markers and brain-derived neurotrophic factor in patients with schizophrenia and those with bipolar disorder[J]. Journal of Clinical Medicine in Practice, 2021, 25(22): 74-77. DOI: 10.7619/jcmp.20212571
    [6]TAN Sanyang, HUANG Hai, LIN Zhangping. Predictive value of umbilical vein blood brain-derived neurotrophic factor level for brain injury of neonates delivered by the pregnant with gestational diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 89-92. DOI: 10.7619/jcmp.20201406
    [7]PAN Xinming, HU Xuefeng, WEN Lu, HU Xiuxiu, ZHANG Xiaobin. Effect of atypical antipsychotics on glial cell line-derived neurotrophic factor levels in schizophrenia patients[J]. Journal of Clinical Medicine in Practice, 2017, (21): 12-14,18. DOI: 10.7619/jcmp.201721003
    [8]DING Zhaosheng, ZHOU Fang, LIN Maming, WANG Yun. Influence and clinical effect of fluoxetine on the level of serum brain-derived neurotrophic factor in patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2012, (24): 17-19.
    [9]LIU Jin-wen, ZHANG Xiao-bin, ZHOU Hong-hui, ZHANG Yu-mei. Study of the serum levels of brain- derived neurotrophic factor and glial cell line- derived neurotrophic factor in patients with recurrent depression[J]. Journal of Clinical Medicine in Practice, 2012, (9): 29-31. DOI: 10.3969/j.issn.1672-2353.2012.09.010
    [10]CAI Yi-yun, SHI Shen-xun, XU San-rong, SUN Da-yu. THE IMPACT OF CHRONIC STRESS ON MONOAMINE NEUROTRANSMITTERS IN CSF OF RATS[J]. Journal of Clinical Medicine in Practice, 2005, (1): 2-4. DOI: 10.3969/j.issn.1672-2353.2005.01.002

  • Cited by

    Periodical cited type(6)

    1. 孟凯. 电视胸腔镜辅助环抱器治疗胸部外伤合并肋骨骨折患者的临床效果观察. 大医生. 2025(04): 23-25 .
    2. 王晓康. 肋骨接骨板置入内固定术对肋骨骨折安全性及疼痛的影响. 中国医药指南. 2024(04): 14-16 .
    3. 成刚，王长兴. 基于胸腔镜的复位内固定术治疗老年肋骨骨折患者的临床疗效研究. 实用临床医药杂志. 2024(05): 89-93 . 本站查看
    4. 彭亮，郭剑，查波辉，吴珊燕，舒华宝，吴胜华，杨子熠，王小娟. 急诊创伤性血气胸在床边超声引导下精准化穿刺置管引流术的治疗效果. 检验医学与临床. 2024(09): 1245-1249 .
    5. 冉隆强，李勇，贾萌. 胸腔镜辅助内固定术对多发肋骨骨折合并胸部创伤患者肺功能及预后的影响. 中国医刊. 2023(05): 517-520 .
    6. 周攀，吴中权，朱杰，舒圣，程玲玲. 胸腔镜微创手术和快速康复治疗严重胸部碾轧伤1例. 中国医药. 2023(08): 1255-1258 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (351) PDF downloads (12) Cited by(6)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return